Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Malignant Mesothelioma through trial conditions or approval indications mapped to it or to one of its descendant entities.
0 drugs · 0 active trials
no drug at this stage
4 drugs · 30 active trials
Data updated 21 minutes agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Elimusertib | Phase 1 | Phase 1 | 1 | 0 | 0 | 1 | 0 | — | — | Aug 25, 2021 |
| Paclitaxel | Phase 1 | Phase 1 | 1 | 1 | 0 | 1 | 0 | — | — | Sep 29, 2021 |
| Venetoclax | Phase 1 | Phase 1 | 1 | 0 | 0 | 1 | 0 | — | — | Jul 25, 2026 |
| Alvocidib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Oct 25, 2004 |
| Azacitidine | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2007-10 |
| Bosutinib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Dec 10, 2019 |
| Cabozantinib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Jan 23, 2020 |
| Decitabine | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 1999-10 |
| Etoposide | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Aug 31, 2018 |
| Fulvestrant | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Jul 31, 2012 |
| Letrozole | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Jul 31, 2012 |
| Nab-paclitaxel | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Jul 27, 2016 |
| Panobinostat | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2007-11 |
| Romidepsin | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Oct 25, 2004 |
| Samotolisib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Jul 31, 2012 |
| Temozolomide | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2007-10 |
| Tofacitinib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Aug 29, 2019 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.